NuShores Biosciences receives $2.8 million contract for intelligent manufacturing automation of bone regeneration technology

NuShores Biosciences, a spin-off company of the University of Arkansas at Little Rock, has received a three-year, $2.8 million contract from the Medical Technology Enterprise Consortium, a biomedical technology consortium associated with the U.S. Army Medical Research and Development Command. The contract will enable NuShores to develop intelligent automated production of its NuCress™ bone void filler scaffold products using its factory-in-a-box concept. Key collaborators on the project include UA Little Rock and MiQ Partners of Cincinnati.

Military medical sponsors award manufacturing development contract to NuShores Biosciences for bone regeneration technology

The University of Arkansas at Little Rock has received state and federal approval to award a services contract to NuShores Biosciences LLC for Generation 1 manufacturing of the NuCress bone void filler scaffold products. This contract is funded by a $5.6 million grant awarded by the Department of Defense to UA Little Rock in 2019.

UA Little Rock announces $750,000 grant for groundbreaking bone regeneration technology

The University of Arkansas at Little Rock announced a $750,000 grant from the U.S. Department of Defense to support the development of potentially life-saving bone regeneration technology during a Nov. 15 visit from Sen. John Boozman. The visit celebrated on-campus research initiatives that the senator championed for federal support.